Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 May;77(10):1711–1712.

5-Fluorouracil-related encephalopathy: at least two distinct pathogenetic mechanisms exist - reply

Kun-Huei Yeh, Ann-Lii Cheng
PMCID: PMC2150055

Full text

PDF
1711

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davis S. T., Joyner S. S., Baccanari D. P., Spector T. 5-Ethynyluracil (776C85): protection from 5-fluorouracil-induced neurotoxicity in dogs. Biochem Pharmacol. 1994 Jul 19;48(2):233–236. doi: 10.1016/0006-2952(94)90092-2. [DOI] [PubMed] [Google Scholar]
  2. Diasio R. B., Beavers T. L., Carpenter J. T. Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity. J Clin Invest. 1988 Jan;81(1):47–51. doi: 10.1172/JCI113308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kerr I. G., Zimm S., Collins J. M., O'Neill D., Poplack D. G. Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey. Cancer Res. 1984 Nov;44(11):4929–4932. [PubMed] [Google Scholar]
  4. SHERLOCK S., SUMMERSKILL W. H., WHITE L. P., PHEAR E. A. Portal-systemic encephalopathy; neurological complications of liver disease. Lancet. 1954 Sep 4;267(6836):454–457. [PubMed] [Google Scholar]
  5. Sinatra F., Yoshida T., Applebaum M., Masion Hoogenraad N. J., Sunshine P. Abnormalities of carbamyl phosphate synthetase and ornithine transcarbamylase in liver of patients with Reye's syndrome. Pediatr Res. 1975 Nov;9(11):829–833. doi: 10.1203/00006450-197511000-00005. [DOI] [PubMed] [Google Scholar]
  6. Snodgrass P. J., DeLong G. R. Urea-cycle enzyme deficiencies and an increased nitrogen load producing hyperammonemia in Reye's syndrome. N Engl J Med. 1976 Apr 15;294(16):855–860. doi: 10.1056/NEJM197604152941601. [DOI] [PubMed] [Google Scholar]
  7. Takimoto C. H., Lu Z. H., Zhang R., Liang M. D., Larson L. V., Cantilena L. R., Jr, Grem J. L., Allegra C. J., Diasio R. B., Chu E. Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency. Clin Cancer Res. 1996 Mar;2(3):477–481. [PubMed] [Google Scholar]
  8. Tuchman M., Stoeckeler J. S., Kiang D. T., O'Dea R. F., Ramnaraine M. L., Mirkin B. L. Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity. N Engl J Med. 1985 Jul 25;313(4):245–249. doi: 10.1056/NEJM198507253130407. [DOI] [PubMed] [Google Scholar]
  9. Yeh K. H., Cheng A. L. High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy. Br J Cancer. 1997;75(3):464–465. doi: 10.1038/bjc.1997.79. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES